Table 2 Characteristics of the selected health facilities
Public facilities N = 72 n (%) | Private facilities N = 72 n (%) | Total N = 144 n (%) | aOR (95 % CI) | P-value | |
|---|---|---|---|---|---|
Availability of malaria diagnostic equipment | |||||
HF with microscopy | 12 (16.7 %) | 18 (25.0 %) | 30 (20.8 %) | 0.6 (0.3–1.4) | 0.220 |
HF with mRDT | 59 (81.9 %)) | 14 (19.4 %) | 73 (50.7 %) | 18.8 (8.1–3.4) | 0.000 |
HF with both microscopy and mRDT | 7 (9.7 %) | 8 (11.1 %) | 15 (10.4 %) | 0.9 (0.3–2.5) | 0.790 |
Availability of recommended antimalarial medicines | |||||
AL | 68 (94.4) | 57 (79.2) | 125 (86.8) | 4.5 (1.4–14.2) | 0.007 |
AA | 58 (80.6) | 52 (72.2) | 110 (76.4) | 1.6 (0.7–3.5) | 0.240 |
Quinine tab | 61 (84.7) | 26 (36.1) | 87 (60.4) | 9.8 (4.4–21.9) | 0.000 |
Quinine Inj. | 43 (59.7) | 18 (25.0) | 61 (42.4) | 4.5 (2.2–9.1) | 0.000 |
Artemether Inj. | 8 (11.1) | 40 (55.6) | 48 (33.3) | 0.1 (0.0–0.2) | 0.000 |
S-P | 65 (90.3) | 55 (76.4) | 120 (83.3) | 2.9 (1.1–7.4) | 0.030 |
Non recommended antimalarial medicines | |||||
Artesunate | 9 (12.5) | 42 (58.3) | 51 (35.4) | 0.1 (0.0–0.2) | 0.000 |
Amodiaquine | 6 (8.3) | 28 (38.9) | 34 (23.6) | 0.1 (0.0–0.4) | 0.0002 |
Chloroquine | 3 (4.2) | 19 (26.4) | 22 (15.3) | 0.1 (0.0–0.4) | 0.002 |
Halofantrine | 2 (2.8) | 8 (11.1) | 10 (6.9) | 0.2 (0.1–1.1) | 0.050 |
Dihydroartemisinin-piperaquine | 2 (2.8) | 5 (6.9) | 7 (4.9) | 0.4 (0.1–2.0) | 0.250 |